Jan 1, 2025 · Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg/50 mL in GALAXY Plastic Container. Liquid Premix. Please refer to full Prescribing Information, including Boxed Warning for Clostridioides difficile-associated …
Clindamycin Injection in 5% Dextrose (clindamycin phosphate) is indicated for the treatment of serious infections due to susceptible anaerobic bacteria, such as Bacteroides species, Peptostreptococcus , anaerobic streptococci, Clostridium …
Jan 1, 2025 · Clindamycin Injection USP in 5% Dextrose, 600 mg/50 mL in GALAXY Plastic Container. Liquid Premix. Please refer to full Prescribing Information, including Boxed Warning for Clostridium difficile-associated diarrhea (CDAD) .
Clindamycin in 5% Dextrose Injection products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. To reduce the development of drug-resistant bacteria and maintain the effectiveness of
Clindamycin in 5% Dextrose Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below: Lower respiratory tract infections including pneumonia, empyema, and lung abscess
The recommended dosing regimen for Clindamycin in 0.9% Sodium Chloride Injection is 600- 1200 mg/day in 2, 3, or 4 equal doses by intravenous infusion for serious infections due to aerobic gram-positive cocci and the more susceptible anaerobes (NOT generally including
Clindamycin Injection in 5% Dextrose 600-900 mg (IV) every 6 hours or 900 mg (IV) every 8 hours in combination with oral daily dose of 15-30 mg of primaquine. Alternatively, clindamycin hydrochloride 300-450 mg may be given orally every 6 hours in combination with 15-30 mg of primaquine for 21 days.